BACKGROUND: Changes within the ABO system are regularly observed phenomena in
allogeneic bone marrow transplantation (BMT) and peripheral blood progenitor cell …

Background Major ABO mismatch between donor and recipient in bone marrow
transplantation (BMT) may cause hemolysis, delayed red blood cell (RBC) engraftment and …

BACKGROUND: Isohemagglutinins directed against the donor blood group frequently delay
erythroid engraftment after major ABO‐mismatched allogeneic hematopoietic progenitor cell …

BACKGROUND: Most studies indicate that ABO incompatibility has no effect on the clinical
outcome after allogeneic peripheral blood progenitor cell (PBPC) transplantation (allo …

ABO blood group antigen incompatibility (ABO mismatch) is not an obstacle to allogeneic
stem cell transplantation (allo‐SCT). However, the impact on clinical outcome after allo‐SCT …

Background To enhance donor availability, almost half of hematopoietic progenitor cell
transplants (HPCTs) cross ABO blood type boundaries. ABO‐incompatible HPCTs are well …

BACKGROUND: Severe immunohematologic complications after ABO‐mismatched
allogeneic blood peripheral blood progenitor cell (PBPC) transplantation (PBPCT), including …

Major ABO incompatibility between donor and recipient is not considered a barrier to
successful allogeneic hematopoietic stem cell transplantation (HSCT), even if it can be …

BACKGROUND Hemolysis at the time of graft infusion is one of the immediate complications
in major ABO‐incompatible allogeneic hematopoietic stem cell transplants (HSCTs). We …

BACKGROUND: Major ABO mismatch in hematopoietic progenitor cell transplantation
(HPCT) is associated with a range of immunohematologic consequences including …